Lipid-lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel
Arrigo F.G. Cicero(IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola), Maciej Banach(Medical University of Lodz), Kausik K. Ray(Imperial College London), Dragoş Vinereanu(Carol Davila University of Medicine and Pharmacy), Christos Pitsavos(National and Kapodistrian University of Athens), Olena Mitchenko(Çevre, Şehircilik ve İklim Değişikliği Bakanlığı), Bernhard Paulweber(Paracelsus Medical University), Maria-Corina Șerban(Victor Babeș University of Medicine and Pharmacy Timișoara), Amirhossein Sahebkar(Mashhad University of Medical Sciences), György Paragh(Roswell Park Comprehensive Cancer Center), Željko Reiner, Alessandro Colletti(Società Italiana di Fisica), М. В. Ежов(Institute of Electronic Measurements KVARZ (Russia)), Dragan Djurić(University of Belgrade), Manfredi Rizzo(Department of Health), Peter P. Tóth(University of Illinois Urbana-Champaign), Michel R. Langlois(University of Pavol Jozef Šafárik), Niki Katsiki(Neurosciences Institute), Gustavs Latkovskis(British Heart Foundation), Demosthenes B. Panagiotakos(Harokopio University of Athens), Nathan D. Wong(University of Washington), Michal Vrablı́k(Charles University), Daniel Pella(Brigham and Women's Hospital), Dimitri P. Mikhailidis(UCL Australia), Olivier Descamps(Hôpital de Jolimont), Laurence Sperling(Emory University), Zlatko Fras(University of Ljubljana), Gani Bajraktari(University Clinical Center of Kosovo)
Cited by 286
Related Papers
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
|New England Journal of Medicine|2017|9.1k
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k